From February 6, 2022 to March 31, 2022, the company has repurchased 680,000 shares, representing 0.21% for CNY 49.85 million. With this, the company has completed the repurchase of 680,000 shares, representing 0.21% for CNY 49.85 million under the buyback announced on February 7, 2022.
Qingdao Haier Biomedical Co.,Ltd
Equities
688139
CNE100003P25
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
36.72 CNY | +0.30% |
|
-5.12% | -9.38% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.38% | 159.22Cr | |
+4.85% | 22TCr | |
+9.86% | 19TCr | |
+31.11% | 15TCr | |
+34.08% | 11TCr | |
+1.90% | 6.4TCr | |
+19.45% | 5.43TCr | |
+1.63% | 4.92TCr | |
-3.12% | 3.94TCr | |
+1.93% | 3.6TCr |
- Stock Market
- Equities
- 688139 Stock
- News Qingdao Haier Biomedical Co.,Ltd
- Tranche Update on Qingdao Haier Biomedical Co., Ltd's Equity Buyback Plan announced on February 7, 2022.